InspireMD raises $23M for MGuard stent | Wall Street Beat

April 22, 2013 by Brad Perriello

InspireMD nets nearly $23 million from a public stock offering, saying it plans to use the proceeds to pursue U.S. approval of its MGuard coronary and carotid stents. Wall Street Beat

InspireMD (OTC:NSPR) said it added some $23 million to its coffers in a public stock offering.

The Tel Aviv-based medical device company makes the MGuard device, designed to protect against embolism after stenting procedures.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.